Panel Detects BCR-ABL1 Oncogene Isoform Co-Expression in CML Patient
The HemeScreen BCR-ABL1 Panel enabled Precipio’s clinical lab to detect a co-expression of both p190 and p210 isoforms in this patient, leading to more informed care decisions.
Category: Leukemia
Leukemia
Latest
Leukemia
Latest
NIH Awards Grant for Autofluorescence-Free Cytometry Development
Kinetic River has been awarded a Phase II SBIR grant for the development of an autofluorescence-free flow cytometry platform.
Leukemia
Latest
Study Offers Promise for Early Detection of Infections among Childhood Leukemia Patients
A noninvasive blood test may provide a ‘crystal ball’ for early detection of infections, leading to increased cure rates among pediatric leukemia patients.
Elevating Pathology
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
Read More
Preliminary Data Confirm Saphyr’s Potential to Replace Traditional Cytogenetics Methods for Detecting Structural Variants in Certain Blood Cancers
Strong concordance with standard-of-care methods shows how the Saphyr mapping system can transform cytogenetic workflows and improve blood cancer treatment.
Read More
Liquid Biopsies Guide Improved Cancer Treatment
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read MoreSaga Raises $4.1 Million to Advance Ultrasensitive Liquid Biopsies
The funds will be used to accelerate commercialization of Saga’s portfolio of kits and services, continue development of new products, and perform prospective clinical studies.
Read MoreCytek Biosciences Debuts Advanced Five-Laser Flow Cytometer
The Aurora system is now available with five lasers, making it possible for researchers to visualize more than 30 colors from a single sample.
Read More
Single-Cell Genomics Study Reveals Clonal Diversity Underlying Resistance to Leukemia Therapy
The study demonstrates the potential for more impactful, dynamic therapy development and applications for those with acute myeloid leukemia.
Read MoreCanopy Biosciences Licenses Technology for Error-Corrected Sequencing
The license encompasses both a novel method and bioinformatic tools that combine to improve the level of detection in NGS, allowing for the identification of ultrarare gene variants.
Read More
Bio-Rad Releases First FDA-Cleared Liquid Biopsy Test for Chronic Myeloid Leukemia
Using the kit, clinicians can accurately and reproducibly monitor residual disease in patients with chronic myeloid leukemia, even at low levels.
Read More
FDA Grants Clearance for OGT’s AML/MDS FISH Probes
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.
Read More
Determining Molecular Response in Chronic Myeloid Leukemia
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
Qiagen Broadens GeneReader NGS System Applications into Hereditary Disease Analysis
New applications include customizable QIAact target enrichment panels for next-generation sequencing of more than 13 hereditary disease groups.
Read More
SeraCare Releases NGS Reference Material for Hematologic Malignancies
SeraCare Life Sciences has expanded its suite of clinical genomics development, validation, and quality control tools with the launch of Seraseq myeloid DNA and myeloid RNA fusion reference materials.
Read More
Bio-Rad Launches Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy
Bio-Rad Laboratories has introduced the QXDx BCR-ABL %IS kit, a CE-marked digital polymerase chain reaction test that can monitor the molecular response to therapy of patients with chronic myeloid leukemia.
Read MoreFDA Grants Clearance for Chronic Myeloid Leukemia Test
Agency allows marketing of the QuantideX qPCR BCR-ABL IS kit, the first nucleic acid-based quantitation test for use during treatment of rare leukemia.
Read More
RainDance Technologies Forms Hematologic Oncology Consortium
After its ASH 2014 debut, the RainDance HemOnc Consortium, an international panel of clinical research experts, will focus on developing assays for liquid biopsy research of myeloid disorders.
Read More